Law360, New York (August 18, 2006) -- Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
In court filings, Apotex said it had alerted the Federal Trade Commission to attempts by a Bristol-Myers executive to mislead the government about secret agreements the pharmaceutical giant made with...
